Levomilnacipran

ATC N06AX28 · 4 markets · 15 records

Levomilnacipran 4 markets · 15 records Forms

CA 8 records · 4 strengths

80 mgcapsule · extended-releaseAPO-LEVOMILNACIPRAN+1Fetzima also in US·GB
40 mgcapsule · extended-releaseAPO-LEVOMILNACIPRAN+1Fetzima also in US·GB
120 mgcapsule · extended-releaseAPO-LEVOMILNACIPRAN+1Fetzima also in US
20 mgcapsule · extended-releaseAPO-LEVOMILNACIPRAN+1Fetzima also in US

US 4 records · 4 strengths

80 mgcapsule · extended-releaseFetzima also in CA·GB
40 mgcapsule · extended-releaseFetzima also in CA·GB
120 mgcapsule · extended-releaseFetzima also in CA
20 mgcapsule · extended-releaseFetzima also in CA

GB 2 records · 2 strengths

80 mgcapsule · extended-releaseFetzima 40mg modified-release capsules also in CA·US
40 mgcapsule · extended-releaseFetzima 40mg modified-release capsules also in CA·US

Side-by-side table

Strength / form / release	US	GB	CA
80 mg capsule · extended-release	Fetzima	Fetzima 40mg modified-release capsules	APO-LEVOMILNACIPRAN Fetzima
40 mg capsule · extended-release	Fetzima	Fetzima 40mg modified-release capsules	APO-LEVOMILNACIPRAN Fetzima
120 mg capsule · extended-release	Fetzima	not recorded	APO-LEVOMILNACIPRAN Fetzima
20 mg capsule · extended-release	Fetzima	not recorded	APO-LEVOMILNACIPRAN Fetzima

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.